Zynerba Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Zynerba Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2023.
  • Zynerba Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2023 was $219K, a 51.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $219K -$233K -51.5% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $278K -$231K -45.4% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $336K -$230K -40.6% Dec 31, 2022 10-Q 2023-08-14
Q3 2022 $394K -$228K -36.6% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $452K -$226K -33.4% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $509K -$225K -30.6% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $566K +$461K +438% Dec 31, 2021 10-K 2023-03-28
Q3 2021 $622K +$455K +273% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $678K +$451K +198% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $734K +$447K +156% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $105K -$241K -69.6% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $167K +$14.7K +9.68% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $228K +$21.3K +10.3% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $287K +$28.4K +11% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $346K Dec 31, 2019 10-K 2021-03-10
Q3 2019 $152K Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $206K Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $259K Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.